Heidelberg University Team Uncovers Novel Molecular Pathway Driving Alzheimer’s Progression, Offering New Therapeutic Avenues
A groundbreaking study spearheaded by Professor Dr. Hilmar Bading, a distinguished neurobiologist at Heidelberg University, has illuminated a critical molecular mechanism at the heart of Alzheimer’s disease progression. Collaborating with…
Scientists Engineer Psilocin Derivatives to Potentially Separate Therapeutic Benefits from Hallucinogenic Effects
The quest to harness the therapeutic potential of psilocybin, the primary psychoactive compound in "magic mushrooms," has taken a significant stride forward with the development of novel psilocin derivatives that…








